During the three months ended June 30, 2025, i3 Verticals, LLC and i3 Healthcare Solutions, LLC, a wholly-owned subsidiary of i3 Verticals, LLC (“Healthcare RCM Seller,” and collectively with i3 Verticals, LLC, the “Healthcare RCM Seller Parties”), completed the sale of the equity interests of certain wholly-owned subsidiaries of the Healthcare RCM Seller (the “Healthcare RCM Acquired Entities”) which owned and operated the Company's healthcare revenue cycle management business, including its associated proprietary technology (the “Healthcare RCM Business”), to Infinx, Inc. (“Healthcare RCM Buyer” or "Infinx"), a Texas corporation, pursuant to the terms of that certain Securities Purchase Agreement dated as of May 5, 2025, by and among Healthcare RCM Buyer and the Healthcare RCM Seller Parties (the “Healthcare RCM Purchase Agreement;” the transactions contemplated by the Healthcare RCM Purchase Agreement, the “Healthcare RCM Transactions”). In addition, immediately prior to the sale of the equity interests of the Healthcare RCM Acquired Entities pursuant to the Healthcare RCM Purchase Agreement, i3 Verticals, LLC and certain of its subsidiaries contributed and/or assigned certain assets and certain liabilities related to the Healthcare RCM Business to the Healthcare RCM Acquired Entities. The purchase price payable by Healthcare RCM Buyer to Healthcare RCM Seller for the equity interests of the Healthcare RCM Acquired Entities was $96,252, paid in cash at closing, after giving effect to post-closing net working capital, indebtedness and cash adjustments. The Healthcare RCM Business comprised the majority of the Company's former Healthcare segment.

At the closing of the transactions contemplated by the Healthcare RCM Purchase Agreement, the Company entered into a transition services agreement with Infinx ("Infinx TSA"), pursuant to which, among other things, the Company or affiliates thereof provided certain information technology and operational transition services to Infinx for a period of time after the closing, and an employee leasing agreement with Infinx ("Infinx ELA"), pursuant to which the Company leased employees of the Healthcare RCM Business to Infinx for a limited period of time following the closing in accordance with the terms thereof. The obligations under the Infinx TSA were substantially completed in the first quarter of fiscal 2026. The Infinx ELA completed on July 31, 2025. Revenue earned under the Infinx TSA and Infinx ELA are reported in other income and expenses incurred for which the Company is reimbursed through the Infinx TSA and Infinx ELA are reported in selling, general and administrative expenses within the Company's condensed consolidated statements of operations. Income under the Infinx TSA was not significant during the three and nine months ended June 30, 2026, and was $3,919 during both the three and nine months ended June 30, 2025.

Aggregate costs incurred related to the sale of the Healthcare RCM Business during the year ended September 30, 2025 that were not considered incremental direct costs to transact the sale, were approximately $1,332 and were expensed as incurred. These costs were primarily incurred during the third fiscal quarter of the fiscal year ended September 30, 2025 and include fees for third-party advisory, consulting, legal and professional services, as well as other items associated with the sale of the Healthcare RCM Business. The expenses are reflected within selling, general and administrative expenses within the Company's condensed consolidated statements of operations.


	Three Months Ended June 30,				Nine Months Ended June 30,
	2026		2025		2026		2025

Revenue	$	—	$	3,601	$	—	$	22,463

Operating expenses
Costs of services (excluding depreciation and amortization)	—		3,023		—		14,553
Selling, general and administrative	—		2,491		—		7,317
Depreciation and amortization	—		275		—		1,940
Change in fair value of contingent consideration	—		10		—		1,302
Total operating expenses	—		5,799		—		25,112

Loss from operations	—		(2,198)		—		(2,649)

Other expenses (income)	250		(25,960)		419		(25,998)

(Loss) income before income taxes from discontinued operations	(250)		23,762		(419)		23,349

(Benefit from) provision for income taxes	(33)		4,337		(64)		4,620

Net (loss) income from discontinued operations	(217)		19,425		(355)		18,729

Net (loss) income from discontinued operations attributed to non-controlling interest	(79)		6,130		(125)		6,041
Net (loss) income from discontinued operations attributable to i3 Verticals, Inc.	$	(138)	$	13,295	$	(230)	$	12,688


	Nine Months Ended June 30, 2025
Depreciation and amortization	$	1,940
Equity-based compensation	$	3,112
Gain on sale of Healthcare RCM Business	$	(25,960)
Non-cash lease expense	$	702
Increase in non-cash contingent consideration expense from original estimate	$	1,302
Contingent consideration paid in excess of original estimates	$	(700)
Expenditures for property and equipment	$	(156)
Expenditures for capitalized software	$	(263)
Proceeds from sale of Healthcare RCM Business, net of cash sold	$	96,102
Cash paid for contingent consideration	$	(800)

During the year ended September 30, 2024, the Company made the strategic decision to discontinue a significant segment of its operations constituting its Merchant Services Business (as defined below). In this regard, on September 20, 2024, i3 Verticals, LLC, and i3 Holdings Sub, Inc., a wholly-owned subsidiary of i3 Verticals, LLC (“Corporation Seller,” and collectively with i3 Verticals, LLC, the “Merchant Services Sellers”) completed the transactions (such closing, the “Closing”) contemplated by that certain Securities Purchase Agreement dated as of June 26, 2024 (the “Merchant Services Purchase Agreement”), by and among i3 Verticals, LLC, Corporation Seller, the Company (solely for the purpose of providing a guaranty of the obligations of Merchant Services Sellers as set forth in the Merchant Services Purchase Agreement), Payroc Buyer, LLC (“Merchant Services Buyer” or "Payroc"), and Payroc WorldAccess, LLC (solely for the purpose of providing a guaranty of the obligations of Merchant Services Buyer as set forth in the Merchant Services Purchase Agreement). Pursuant to the terms of the Merchant Services Purchase Agreement, the Merchant Services Sellers sold to Merchant Services Buyer the equity interests of certain direct and indirect wholly-owned subsidiaries of the Merchant Services Sellers (the “Merchant Services Acquired Entities”) primarily comprising the Company’s merchant services business, including its associated proprietary technology (the “Merchant Services Business”), after giving effect to the contribution of certain assets and the assignment of certain liabilities associated with the Merchant Services Business from i3 Verticals, LLC and certain affiliates to the Merchant Services Acquired Entities pursuant to a contribution agreement which was entered into immediately prior to the Closing (collectively, the "Merchant Services Transactions"). Pursuant to the terms of the Merchant Services Purchase Agreement, Merchant Services Buyer paid to the Merchant Services Sellers an aggregate purchase price of approximately $439,516 paid in cash at closing, after giving effect to post-closing net working capital, indebtedness and cash adjustments. The Merchant Services Business comprised the Company's entire former Merchant Services segment and a small portion of the Company's former Software and Services segment.

after the closing, and a processing services agreement with Payroc ("Payroc PSA"), pursuant to which the parties provide certain payment processing services to customers of each party following the closing in accordance with the terms thereof. The obligations under the Payroc TSA were substantially complete as of December 31, 2025. The obligations under the Payroc PSA are planned to be complete in the first quarter of fiscal 2029. Revenue earned under the Payroc TSA and Payroc PSA are reported in other income, and expenses incurred for which the Company is reimbursed through the Payroc TSA and Payroc PSA are reported in selling, general and administrative expenses within the Company's condensed consolidated statements of operations. Income under the Payroc TSA and Payroc PSA was not significant during the three and nine months ended June 30, 2026, and was $318 and $1,274 during the three and nine months ended June 30, 2025, respectively.



	Three Months Ended June 30, 2025		Nine Months Ended June 30, 2025

Revenue	$	—	$	—

Operating expenses
Costs of services (excluding depreciation and amortization)	—		—
Selling, general and administrative	—		—
Depreciation and amortization	—		—
Total operating expenses	—		—

Income from operations	—		—

Other expenses	4		661

Loss before income taxes from discontinued operations	(4)		(661)

Benefit from income taxes	—		(117)

Net loss from discontinued operations	(4)		(544)

Net loss from discontinued operations attributed to non-controlling interest	(1)		(176)
Net loss from discontinued operations attributable to i3 Verticals, Inc.	$	(3)	$	(368)